ERBB2 and glioma: Cdk4 is required for ErbB-2-driven mammary tumorigenesis, DMBA/TPA-induced skin tumor development, Men1+/−-driven neuroendocrine tumorigenesis, PDGF-induced glioma and APCMin/+-driven adenoma [44,45,46,47,48,49].